Compounds With Modifying Activity Enhanced Under Hypoxic Conditions
    2.
    发明申请
    Compounds With Modifying Activity Enhanced Under Hypoxic Conditions 有权
    低氧条件下改性活性增强的化合物

    公开(公告)号:US20150152390A1

    公开(公告)日:2015-06-04

    申请号:US14531774

    申请日:2014-11-03

    IPC分类号: C12N5/09

    摘要: Compositions and methods for modifying one or more biologic targets are provided. Suitable targets include cells, DNA, proteins, enzymes, and/or a subject in need thereof. The compositions may exist as a monomer or multimer and are active in a biologic environment with enhanced activity in hypoxic environments and, thus, exhibit improved specificity for hypoxic biologic targets (e.g., tumorigenic cells and those undergoing uncontrolled cell growth). A composition typically comprises a complex with an overall charge of 2+ or greater having at least one ruthenium atom attached to a redox active ligand. The redox active ligand helps maintain separation of more than one ruthenium atom. Suitable compositions may further include a terminal ligand comprising a heterocyclic aromatic compound. When provided to a biologic target, the composition modifies the biologic target and no additional compounds need be provided. Suitable compositions are typically catalytic and regenerative in the presence of a reducing agent.

    摘要翻译: 提供了修改一个或多个生物靶标的组合物和方法。 合适的靶标包括细胞,DNA,蛋白质,酶和/或有需要的受试者。 组合物可以作为单体或多聚体存在,并且在缺氧环境中具有增强活性的生物环境中具有活性,因此对缺氧生物靶标(例如致瘤细胞和经受不受控制的细胞生长的那些)表现出改善的特异性。 组合物通常包含具有2+或更大的总电荷的复合物,其具有连接到氧化还原活性配体的至少一个钌原子。 氧化还原活性配体有助于保持多于一个钌原子的分离。 合适的组合物还可以包括包含杂环芳族化合物的末端配体。 当提供给生物靶标时,组合物修饰生物靶标,不需要提供其他化合物。 合适的组合物通常在还原剂存在下是催化和再生的。

    Compounds with modifying activity enhanced under hypoxic conditions

    公开(公告)号:US09816075B2

    公开(公告)日:2017-11-14

    申请号:US14531774

    申请日:2014-11-03

    摘要: Compositions and methods for modifying one or more biologic targets are provided. Suitable targets include cells, DNA, proteins, enzymes, and/or a subject in need thereof. The compositions may exist as a monomer or multimer and are active in a biologic environment with enhanced activity in hypoxic environments and, thus, exhibit improved specificity for hypoxic biologic targets (e.g., tumorigenic cells and those undergoing uncontrolled cell growth). A composition typically comprises a complex with an overall charge of 2+ or greater having at least one ruthenium atom attached to a redox active ligand. The redox active ligand helps maintain separation of more than one ruthenium atom. Suitable compositions may further include a terminal ligand comprising a heterocyclic aromatic compound. When provided to a biologic target, the composition modifies the biologic target and no additional compounds need be provided. Suitable compositions are typically catalytic and regenerative in the presence of a reducing agent.